This week, Congress reached a bipartisan healthcare deal as part of a larger $1.2 trillion spending bill, combining funding increases, policy reforms and program extensions. The proposal maintains key programs like CMS coverage for telehealth and hospital-at-home care, but stops short of renewing enhanced ACA premium tax credits.
The DEA extended telemedicine prescribing flexibilities for controlled substances through the end of 2026, drawing praise from telehealth advocates who are urging a permanent solution.
In a landscape where complexity has long been the norm, the power of one lies not just in unification, but in intelligence and automation.
HHS proposed changes that would roll back many Biden-era policies, eliminate most health tech certification criteria,and scrap planned transparency requirements for healthcare AI tools. The agency argues the move will reduce regulatory burden and save developers time and money.
The FDA will remove black box warnings on hormone replacement therapies after evidence showed the risks were overstated.
How many companies will be left standing once consolidation hits the AI in healthcare sector? Which pharma companies are working with the Trump administration to lower costs?
The latest episode of the Debunked podcast explores an ongoing debate questioning the role of payers in healthcare transactions. It also highlights turmoil at the CDC.
In a recent interview, Esperion president and CEO, Sheldon Koenig talks about the reality of statin intolerance and his company’s expansion into new diseases
The Trump administration's Make America Healthy Again nutrition policies and Medicare Advantage plan ethics were prominent themes on the latest episode of the Debunked Podcast with MedCity News Editor-in-Chief Arundhati Parmar and guest co-host Paul Markovich, CEO of Blue Shield of California parent company Ascendiun.
Health and Human Services Secretary Robert F. Kennedy Jr. is cancelling 22 mRNA vaccine contracts funded by BARDA. Without evidence, Kennedy claimed these vaccines fail to protect effectively against upper respiratory tract infections.
The Train More Nurses Act would help address these challenges by directing the U.S. Department of Health and Human Services (HHS), as well as the U.S. Labor Department, to conduct a review of nursing grant programs to identify opportunities to increase faculty at nursing schools nationwide, especially in underserved communities.
It’s a meaningful step. But declarations alone won’t fix a system still powered by fax machines, phone calls, and inconsistent rules. Real progress will require a modern digital infrastructure, aligned incentives, and coordinated action across both the public and private sectors.
Across the nation, state-based health insurance exchanges are searching for ways to better serve their communities while making enrollment easier, more personal, and more accessible for everyone.
HHS Secretary Robert F. Kennedy Jr. is reportedly planning to dismiss all 16 members of the U.S. Preventive Services Task Force, a panel that decides which preventive care services are fully covered by payers. This has sparked concern from healthcare leaders who warn it could undermine access to important cancer screenings, as well as vital services for children.
Numerous advocacy organizations are sounding the alarm over a recent HHS notice that restricts access to federal benefits for undocumented immigrants, as well as for those lawfully present.
A group of Democratic attorneys general filed a lawsuit against HHS and CMS, arguing that their recent final rule will harm access to care under the Affordable Care Act.
From mobile documentation to emergency handoffs, EMS providers handle sensitive patient information in fast-moving environments. Understanding how HIPAA applies — and how to comply — can improve care, reduce risk, and build systemwide trust.
But where do truth and trust originate in healthcare marketing? They emerge from various sources such as digital advertising, educational campaigns, patient journeys, and partnerships with healthcare providers who uphold truth in advertising standards.